Load up on

Procter & Gamble

(PG) - Get Report

and sell

Estee Lauder

(EL) - Get Report

, James Cramer said on his

"RealMoney" radio show Tuesday.

Procter & Gamble reaffirmed guidance late Monday, while Estee Lauder previewed a "shockingly bad" quarter, Cramer said. The cosmetics giant blamed weakness at high-end department stores, but Cramer said the real problem is Estee Lauder's management.

High-end products and high-end retailers are doing very well right now, said Cramer, as rich consumers keep spending. Those stocks should be "more valuable in an economy where everything else is slowing down," said Cramer. So Procter & Gamble is the "wheat" and Estee Lauder is the "chaff," Cramer said.

Another company playing the blame game is


(TPX) - Get Report

. Cramer said for a mattress company to blame car industry incentives for a sales shortfall is "shameful" and "silly." Sell the stock, said Cramer, who said he expects the stock to hit $5. Tempur-Pedic traded at $11.91 Tuesday afternoon.

A caller asked if

Chesapeake Energy

(CHK) - Get Report

is ripe for a buy. Cramer said the company Monday announced a "very expensive" acquisition of some natural gas properties in Texas but that the company is "probably the most technologically savvy" in extracting gas by nonconventional methods. If the stock comes in, "I certainly want to buy it," said Cramer.

Image placeholder title

Another caller asked if


( CD) is a buy. Cramer said he is confident Cendant's deal to sell its affinity marketing business will go through. Once Cendant has the cash from that sale, he believes Cendant will "reconstitute the company" and announce a "bountiful" buyback, which will make Cendant the must-own travel and leisure company. Even with gas at $3 a gallon, Cendant is a "great long-term story" and "should be bought and bought aggressively," Cramer said.

In response to a question about


(PNC) - Get Report

, Cramer said he thinks people should "ring the register."

Cramer is bullish on

Johnson Controls

(JCI) - Get Report

, saying its acquisition of


( YRK) is a "good deal," and he likes the way Johnson Controls is diversifying away from autos.

Cramer is bearish on


(F) - Get Report



(VC) - Get Report

, adding that Visteon has had a big run due to a short squeeze and that it's now time to sell.

Cramer likes


(TM) - Get Report

as a play on hybrid vehicles because Toyota has extra manufacturing capacity for producing the vehicles.

Modine Manufacturing

(MOD) - Get Report

has been a "fantastic" stock and deserves to go higher.


( DPH) is headed for bankruptcy and Cramer does not want to go anywhere near the stock.

Cramer would not recommend

Owens Corning


as a hurricane play despite prices for building materials being "sky high," because he isn't sure what will happen to the company's common stock once the company emerges from bankruptcy.

Cramer is bullish on


(UNH) - Get Report

. He would buy the stock at $50 and believes it will be "easy" for the stock to go to $60. Ultimately he expects UNH to go to $70. UnitedHealth Group traded at $52.94 late Tuesday.

Cramer would sell


( CIN) in advance of its being acquired by

Duke Energy

(DUK) - Get Report

, adding that there's "not that much left here."

Cramer is bullish on


(SLB) - Get Report

, saying he believes the 52nd largest publicly-held U.S. company is destined to become one of the top 10 largest, as it was in 1982.

Cramer said he would buy the stock of

Capstone Turbine

(CPST) - Get Report

at $4, adding that his research assistant Will Gabrielski believes there are more important deals than the company's deal with UTC Power. Capstone traded at $4.27 late Tuesday.

Finally, Cramer said it was a "mistake" for the

Federal Reserve

to raise interest rates today and that Fed Chairman Allan Greenspan is "killing" the stock market.

Interested in more Cramer? Check out Jim's rules and commandments for investing from his latest book by

clicking here

. It's a series of articles from Cramer on how to become a better investor. The following table lists some of the rules that Cramer dissects.

At the time of publication, Cramer was long Cendant and UnitedHealth.

James J. Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by

clicking here. Listen to Cramer's RealMoney Radio show on your computer; just click

here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click

here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict."